I bought a few years ago at 2.2c, and over the last year my conviction has grown. This morning i bought more with my super. So in total it represents about 40% of my stock portfolio. For me it has the same potential as BRN and i think the probability of success is similar. However at current prices i think IMU is cheap, and BRN is a tad overvalued (since it had the FOMO rally). Fundamentally the company keeps progressing well and has collaborations with big pharmacuetical companies, who i think are ready to buy out within a year, one or more of their 4 products being tested. The lowlights is the manipulation since entering the ASX 200. There is no good reason for the decline from 60 to 30c based on the progression in the corresponding 3 months. The highlights is the company announcements and communication to shareholders is excellent. Similar to BRN, i trust the management because they have delivered on what they have said they will do.